Your browser doesn't support javascript.
loading
Epigenetic tuning of PD-1 expression improves exhausted T cell function and viral control.
Weiss, Sarah A; Huang, Amy Y; Fung, Megan E; Martinez, Daniela; Chen, Alex C Y; LaSalle, Thomas J; Miller, Brian C; Scharer, Christopher D; Hegde, Mudra; Nguyen, Thao H; Rowe, Jared H; Osborn, Jossef F; Patterson, Dillon G; Sifnugel, Natalia; Mei-An Nolan, C; Davidson, Richard A; Schwartz, Marc A; Bally, Alexander P R; Neeld, Dennis K; LaFleur, Martin W; Boss, Jeremy M; Doench, John G; Nicholas Haining, W; Sharpe, Arlene H; Sen, Debattama R.
Affiliation
  • Weiss SA; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Huang AY; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Fung ME; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Martinez D; Division of Medical Sciences, Harvard Medical School, Boston, MA, USA.
  • Chen ACY; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • LaSalle TJ; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Miller BC; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Scharer CD; Division of Population Sciences, Dana-Farber Cancer Institute, Boston, MA, USA.
  • Hegde M; Department of Immunology, Blavatnik Institute, Harvard Medical School, Boston, MA, USA.
  • Nguyen TH; Gene Lay Institute of Immunology and Inflammation, Brigham and Women's Hospital, Massachusetts General Hospital and Harvard Medical School, Boston, MA, USA.
  • Rowe JH; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Osborn JF; Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Patterson DG; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Sifnugel N; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Mei-An Nolan C; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
  • Davidson RA; Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Schwartz MA; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Bally APR; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Neeld DK; Broad Institute of Harvard and Massachusetts Institute of Technology, Cambridge, MA, USA.
  • LaFleur MW; Krantz Family Center for Cancer Research, Department of Medicine, Massachusetts General Hospital, Boston, MA, USA.
  • Boss JM; Department of Medicine, Harvard Medical School, Boston, MA, USA.
  • Doench JG; Center for Immunology and Inflammatory Diseases, Massachusetts General Hospital, Boston, MA, USA.
  • Nicholas Haining W; Department of Medicine, Division of Oncology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Sharpe AH; Department of Genetics, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
  • Sen DR; Department of Microbiology and Immunology, University of North Carolina at Chapel Hill, Chapel Hill, NC, USA.
Nat Immunol ; 25(10): 1871-1883, 2024 Oct.
Article in En | MEDLINE | ID: mdl-39289557
ABSTRACT
PD-1 is a key negative regulator of CD8+ T cell activation and is highly expressed by exhausted T cells in cancer and chronic viral infection. Although PD-1 blockade can improve viral and tumor control, physiological PD-1 expression prevents immunopathology and improves memory formation. The mechanisms driving high PD-1 expression in exhaustion are not well understood and could be critical to disentangling its beneficial and detrimental effects. Here, we functionally interrogated the epigenetic regulation of PD-1 using a mouse model with deletion of an exhaustion-specific PD-1 enhancer. Enhancer deletion exclusively alters PD-1 expression in CD8+ T cells in chronic infection, creating a 'sweet spot' of intermediate expression where T cell function is optimized compared to wild-type and Pdcd1-knockout cells. This permits improved control of chronic infection without additional immunopathology. Together, these results demonstrate that tuning PD-1 via epigenetic editing can reduce CD8+ T cell dysfunction while avoiding excess immunopathology.
Subject(s)

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mice, Knockout / CD8-Positive T-Lymphocytes / Epigenesis, Genetic / Programmed Cell Death 1 Receptor / Mice, Inbred C57BL Limits: Animals Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos

Full text: 1 Collection: 01-internacional Database: MEDLINE Main subject: Mice, Knockout / CD8-Positive T-Lymphocytes / Epigenesis, Genetic / Programmed Cell Death 1 Receptor / Mice, Inbred C57BL Limits: Animals Language: En Journal: Nat Immunol Journal subject: ALERGIA E IMUNOLOGIA Year: 2024 Document type: Article Affiliation country: Estados Unidos Country of publication: Estados Unidos